A Database Survey of Comparison The Risk of Haemorrhage Between Vortioxetine Tablet Treatment and Selective Serotonin Reuptake Inhibitor (SSRI) Treatment in Participants With Depression

CompletedOBSERVATIONAL

Enrollment

147,777

Participants

Timeline

Start Date

June 1, 2024

Primary Completion Date

September 9, 2024

Study Completion Date

September 9, 2024

Conditions

Major Depressive Disorder

Interventions

DRUG

Vortioxetine Tablet

DRUG

SSRI

SSRI: Selective Serotonin Reuptake Inhibitor

Trial Locations (1)

Takeda Selected Site, Tokyo